Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06222606 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jan 2026 to Jan 2027 Enrollment target: 110 to 160 · Site details revisedv3 Show 2 more changesShow less
    • Enrollment target: 110 to 160
    • Site details revised
  2. Start date changed from estimate of Jan 2024 to Jan 1, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).
Trial Details
NCT Number NCT06222606
Lead Sponsor Aarhus University Hospital
Conditions Thyroid Cancer
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov